Related Experiment Video
Updated: Aug 13, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
p73, the "assistant" guardian of the genome?
1Biochemistry Laboratory, IDI-IRCCS, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. gm89@le.ac.uk
Abstract:
Although p53 is clearly involved in the salvage pathway to DNA damage, its frequent mutations do not explain the efficacy of radiotherapy and chemotherapy. Indeed, around 50% of all human cancers show mutations in p53, and a further fraction show a functional inactivation of the protein. Nevertheless, patients seem to respond to therapy that would otherwise require a functional p53. At least in part, these responses could be explained by the pathway mediated by p73. This mechanism is parallel to, but independent of the p53 pathway. Several pieces of evidence show a significant interaction between these two proteins. Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the "assistant" guardian of the genome!
Insights
The p53 protein, crucial for DNA damage repair, is often mutated in cancers. The p73 protein offers a parallel pathway, explaining treatment efficacy despite p53 mutations and acting as an assistant guardian of the genome.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The tumor suppressor protein p53 plays a vital role in DNA damage response pathways.
- Approximately 50% of human cancers harbor p53 mutations, with others exhibiting functional inactivation.
- The efficacy of radiotherapy and chemotherapy in p53-mutated cancers suggests alternative survival mechanisms.
Purpose of the Study:
- To investigate the role of the p73 protein in mediating cellular responses to DNA damage.
- To explore the relationship between p53 and p73 pathways in the context of cancer therapy.
- To understand how functional p73 can compensate for p53 loss in cancer treatment.
Main Methods:
- Review of existing literature on p53 and p73 pathways.
- Analysis of experimental evidence demonstrating interactions between p53 and p73.
- Comparative study of cellular responses in the presence and absence of functional p53.
Main Results:
- The p73 protein mediates a DNA damage salvage pathway parallel to, yet independent of, p53.
- Evidence indicates significant interactions between p53 and p73 proteins.
- Functional p73 can contribute to the efficacy of cancer therapies even when p53 is inactivated.
Conclusions:
- The p73 pathway provides a crucial compensatory mechanism for p53 loss in cancer.
- p73 acts as an 'assistant guardian of the genome,' complementing the role of p53.
- Understanding the p73 pathway is essential for developing more effective cancer treatments.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

